NCT01351909

Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2011-05-02Est. Completion: 2016-11-25

Enrollment target: 35 participants

Locations

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Montefiore Medical Center-Einstein Campus, The Bronx, New York, United States
Montefiore Medical Center-Weiler Hospital, The Bronx, New York, United States
Montefiore Medical Center - Moses Campus, The Bronx, New York, United States

Breast Cancer

The goal of this study is to evaluate the efficacy and safety of tucatinib in combination with trastuzumab and capecitab…

Nagoya, JapanEst. completion Jul 17, 2023

Breast Cancer

The purpose of this study is to assess the efficacy and safety of a novel immunotherapy candidate, tobemstomig, in combi…

Los Alamitos, United StatesEst. completion Oct 19, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.